Hackman Acquires FENNEC PHARMACEUTICALS INC. Shares

Jeffrey S. Hackman, Chief Executive Officer and Director of FENNEC PHARMACEUTICALS INC., acquired 1159 common shares on September 30, 2026. The shares were released from restriction from an award granted on March 28, 2025. The acquisition was made at a price of $0.0 per share. Following this transaction, Hackman owns 67,461 shares directly. This transaction is reported on Form 4 and is classified as an insider transaction.